Your browser doesn't support javascript.
loading
Burden of child mortality from malaria in high endemic areas: Results from the CHAMPS network using minimally invasive tissue sampling.
Ogbuanu, Ikechukwu U; Otieno, Kephas; Varo, Rosauro; Sow, Samba O; Ojulong, Julius; Duduyemi, Babatunde; Kowuor, Dickens; Cain, Carrie Jo; Rogena, Emily A; Onyango, Dickens; Akelo, Victor; Tippett Barr, Beth A; terKuile, Feiko; Kotloff, Karen L; Tapia, Milagritos D; Keita, Adama Mamby; Juma, Jane; Assefa, Nega; Assegid, Nardos; Acham, Yenework; Madrid, Lola; Scott, J Anthony G; Arifeen, Shams El; Gurley, Emily S; Mahtab, Sana; Dangor, Ziyaad; Wadula, Jeannette; Dutoit, Jeanie; Madhi, Shabir A; Mandomando, Inácio; Torres-Fernandez, David; Kincardett, Milton; Mabunda, Rita; Mutevedzi, Portia; Madewell, Zachary J; Blau, Dianna M; Whitney, Cynthia G; Samuels, Aaron M; Bassat, Quique.
Afiliación
  • Ogbuanu IU; Crown Agents in Sierra Leone, Freetown, Sierra Leone.
  • Otieno K; Kenya Medical Research Institute, Centre for Global Health Research, Kisumu, Kenya.
  • Varo R; ISGlobal - Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça [CISM], Maputo, Mozambique.
  • Sow SO; Centre pour le Développement des Vaccins (CVD-Mali), Ministère de la Santé, Bamako, Mali.
  • Ojulong J; Crown Agents in Sierra Leone, Freetown, Sierra Leone.
  • Duduyemi B; University of Sierra Leone Teaching Hospital Complex, Freetown, Sierra Leone.
  • Kowuor D; Crown Agents in Sierra Leone, Freetown, Sierra Leone.
  • Cain CJ; World Hope International, Makeni, Sierra Leone.
  • Rogena EA; School of Medicine, Jomo Kenyatta University of Agriculture and Technology, Juja, Kenya.
  • Onyango D; Kisumu County Department of Health, Kisumu, Kenya.
  • Akelo V; US Centers for Disease Control and Prevention--Kenya, Kisumu, Kenya.
  • Tippett Barr BA; US Centers for Disease Control and Prevention--Kenya, Kisumu, Kenya.
  • terKuile F; Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
  • Kotloff KL; Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Tapia MD; Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Keita AM; Centre pour le Développement des Vaccins (CVD-Mali), Ministère de la Santé, Bamako, Mali.
  • Juma J; Centre pour le Développement des Vaccins (CVD-Mali), Ministère de la Santé, Bamako, Mali.
  • Assefa N; College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.
  • Assegid N; College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
  • Acham Y; College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
  • Madrid L; College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.
  • Scott JAG; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
  • Arifeen SE; International Center for Diarrhoeal Diseases Research (ICDDR,B), Dhaka, Bangladesh.
  • Gurley ES; International Center for Diarrhoeal Diseases Research (ICDDR,B), Dhaka, Bangladesh; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Mahtab S; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Dangor Z; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Wadula J; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Dutoit J; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Madhi SA; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Wits Infectious Diseases and Oncology Research Institute, Faculty of Health Sciences, University of the Witwatersr
  • Mandomando I; ISGlobal - Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça [CISM], Maputo, Mozambique; Instituto Nacional de Saúde, Ministério de Saúde, Maputo, Moçambique.
  • Torres-Fernandez D; ISGlobal - Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça [CISM], Maputo, Mozambique.
  • Kincardett M; Centro de Investigação em Saúde de Manhiça [CISM], Maputo, Mozambique.
  • Mabunda R; Centro de Investigação em Saúde de Manhiça [CISM], Maputo, Mozambique.
  • Mutevedzi P; Emory Global Health Institute, Emory University, Atlanta, GA, USA.
  • Madewell ZJ; Global Health Center, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Blau DM; Global Health Center, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Whitney CG; Emory Global Health Institute, Emory University, Atlanta, GA, USA.
  • Samuels AM; Global Health Center, Centers for Disease Control and Prevention, Atlanta, GA, USA; Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Kisumu, Kenya.
  • Bassat Q; ISGlobal - Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça [CISM], Maputo, Mozambique; ICREA, Pg. Lluís Companys 23, 08010 Barcelona, Spain; Pediatrics Department, Hospital Sant Joan de Déu, Universitat de Barcelona, Esplugues, Barcelona, Spain
J Infect ; 88(3): 106107, 2024 Mar.
Article en En | MEDLINE | ID: mdl-38290664
ABSTRACT

BACKGROUND:

Malaria is a leading cause of childhood mortality worldwide. However, accurate estimates of malaria prevalence and causality among patients who die at the country level are lacking due to the limited specificity of diagnostic tools used to attribute etiologies. Accurate estimates are crucial for prioritizing interventions and resources aimed at reducing malaria-related mortality.

METHODS:

Seven Child Health and Mortality Prevention Surveillance (CHAMPS) Network sites collected comprehensive data on stillbirths and children <5 years, using minimally invasive tissue sampling (MITS). A DeCoDe (Determination of Cause of Death) panel employed standardized protocols for assigning underlying, intermediate, and immediate causes of death, integrating sociodemographic, clinical, laboratory (including extensive microbiology, histopathology, and malaria testing), and verbal autopsy data. Analyses were conducted to ascertain the strength of evidence for cause of death (CoD), describe factors associated with malaria-related deaths, estimate malaria-specific mortality, and assess the proportion of preventable deaths.

FINDINGS:

Between December 3, 2016, and December 31, 2022, 2673 deaths underwent MITS and had a CoD attributed from four CHAMPS sites with at least 1 malaria-attributed death. No malaria-attributable deaths were documented among 891 stillbirths or 924 neonatal deaths, therefore this analysis concentrates on the remaining 858 deaths among children aged 1-59 months. Malaria was in the causal chain for 42.9% (126/294) of deaths from Sierra Leone, 31.4% (96/306) in Kenya, 18.2% (36/198) in Mozambique, 6.7% (4/60) in Mali, and 0.3% (1/292) in South Africa. Compared to non-malaria related deaths, malaria-related deaths skewed towards older infants and children (p < 0.001), with 71.0% among ages 12-59 months. Malaria was the sole infecting pathogen in 184 (70.2%) of malaria-attributed deaths, whereas bacterial and viral co-infections were identified in the causal pathway in 24·0% and 12.2% of cases, respectively. Malnutrition was found at a similar level in the causal pathway of both malaria (26.7%) and non-malaria (30.7%, p = 0.256) deaths. Less than two-thirds (164/262; 62.6%) of malaria deaths had received antimalarials prior to death. Nearly all (98·9%) malaria-related deaths were deemed preventable.

INTERPRETATION:

Malaria remains a significant cause of childhood mortality in the CHAMPS malaria-endemic sites. The high bacterial co-infection prevalence among malaria deaths underscores the potential benefits of antibiotics for severe malaria patients. Compared to non-malaria deaths, many of malaria-attributed deaths are preventable through accessible malaria control measures.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mortalidad del Niño / Malaria Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Límite: Child / Female / Humans / Infant / Newborn / Pregnancy Idioma: En Revista: J Infect Año: 2024 Tipo del documento: Article País de afiliación: Sierra Leona

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mortalidad del Niño / Malaria Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Límite: Child / Female / Humans / Infant / Newborn / Pregnancy Idioma: En Revista: J Infect Año: 2024 Tipo del documento: Article País de afiliación: Sierra Leona